| Literature DB >> 24134193 |
Anna-Lena Cedströmer1, Anna Andlin-Sobocki, Lillemor Berntson, Britt Hedenberg-Magnusson, Lars Dahlström.
Abstract
BACKGROUND: Juvenile idiopathic arthritis (JIA) is a heterogeneous disease that frequently affects also the temporomandibular joint (TMJ) and associated structures. The main aim of this observational study was to describe systematically orofacial clinical signs and subjective symptoms in JIA patients, classified according to the International League of Associations for Rheumatology (ILAR) criteria, and to relate the findings to disease activity and radiological TMJ condyle lesions.Entities:
Year: 2013 PMID: 24134193 PMCID: PMC3854122 DOI: 10.1186/1546-0096-11-37
Source DB: PubMed Journal: Pediatr Rheumatol Online J ISSN: 1546-0096 Impact factor: 3.054
Distribution of gender, age at disease onset, and disease duration in 266 patients with JIA allocated to the ILAR categories
| n (% girls) | 266 (76) | 5 (40) | 97 (77) | 38 (82) | 68 (81) | 15 (93) | 25 (76) | 5 (40) | 13 (38) |
| Onset age, mean, 25/75th percentile yrs | 7.1 (3.0/10.7) | 3.3 (2.1/3.9) | 6.1 (2.2/9.5) | 5.7 (2.6/8.1) | 7.4 (3.5/10.6) | 11.9 (9.9/14.4) | 8.8 (5.0/12.9) | 11.1 (10.1/12.5) | 9.5 (7.3/11.7) |
| Mean disease duration at study visit, 25/75th percentile yrs | 2.9 (0.4/5.4) | 4.8 (0.6/7.1) | 2.5 (0,3/4,3) | 4.2 (0.7/7.6) | 2.7 (0.4/4.2) | 0.8 (0.2/1.7) | 3.0 (0.4/5.9) | 1.2 (0.4/1.1) | 3.5 (0.7/5.8) |
Figure 1Distribution of clinical signs, Di and symptoms, Ai. Distribution (%) by Helkimo’s dysfunction index, Di 0-III and Helkimo’s anamnestic index, Ai 0-II, of 266 JIA patients allocated to the ILAR categories. Di 0 denotes clinically no signs, Di I mild, Di II moderate, and Di III severe signs of dysfunction of the masticatory system. Ai 0 denotes complete absence of subjective symptoms, Ai I mild, and Ai II severe symptoms of the masticatory system.
Figure 2Distribution of disease activity, EU. Distribution (%) of disease activity according to the modified European League Against Rheumatism, EULAR (EU1-EU5) criteria, in 266 patients with JIA allocated to the ILAR categories. EU 1 denotes active disease (increasing number of engaged joints), EU 2 denotes stable disease (unchanged number of engaged joints), EU 3 denotes an inactive disease with treatment (no disease activity), EU 4 denotes an inactive disease without treatment (no disease activity and no treatment less than two years) and EU 5 denotes remission of the disease (no disease activity and no treatment for more than two years).
Distribution of panoramic examinations, clinical signs, Di, subjective symptoms, Ai, and condylar alterations in 130 patients with JIA allocated to the ILAR categories
| Panoramic examination,n(%) | 130 | 3 (2) | 50 (39) | 9 (7) | 36 (28) | 9 (7) | 13 (10) | 2 (2) | 8 (6) |
| Di 0 | 45(35) | 1(33) | 22(44) | 4(44) | 12(33) | 2(22) | 1(8) | 1(50) | 2(25) |
| Di I | 24(19) | 1(33) | 12(24) | 0 | 5(14) | 3(33) | 2(15) | 0 | 1(13) |
| Di II | 44(34) | 0 | 13(26) | 3(33) | 13(36) | 3(33) | 7(54) | 1(50) | 4(50) |
| Di III | 17(13) | 1(33) | 3(6) | 2(22) | 6(17) | 1(11) | 3(23) | 0 | 1(13) |
| Ai 0 | 73(56) | 1(33) | 34(68) | 7(78) | 19(53) | 5(56) | 3(23) | 1(50) | 3(38) |
| Ai I | 11(9) | 1(33) | 4(8) | 0 | 2(1) | 1(11) | 2(15) | 0 | 1(13) |
| Ai II | 46(35) | 1(33) | 12(24) | 2(22) | 15(42) | 3(33) | 8(62) | 1(50) | 4(50) |
| Condylar alteration, n (%) | 48 (37) | 0 | 17 (34) | 7 (78) | 9 (25) | 6 (67) | 7 (54) | 0 | 2 (25) |